Application status and research progress of targeted therapy drugs for hormone receptor-positive breast cancer.

Luo H, Sun Y, Xu T

Open source

DOI: 10.3389/fmed.2025.1513836
Published: 2025
Container: Frontiers in medicine
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2025.1513836,
  title = {Application status and research progress of targeted therapy drugs for hormone receptor-positive breast cancer.},
  author = {Luo H and Sun Y and Xu T},
  year = {2025},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2025.1513836},
  url = {https://doi.org/10.3389/fmed.2025.1513836}
}

RIS

TY  - JOUR
TI  - Application status and research progress of targeted therapy drugs for hormone receptor-positive breast cancer.
AU  - Luo H
AU  - Sun Y
AU  - Xu T
PY  - 2025
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2025.1513836
UR  - https://doi.org/10.3389/fmed.2025.1513836
ER  -

APA

H, L., Y, S., & T, X. (2025). Application status and research progress of targeted therapy drugs for hormone receptor-positive breast cancer.. Frontiers in medicine. https://doi.org/10.3389/fmed.2025.1513836

Source records

pubmed · retrieved 2026-11-10T18:04:55.815Z
europe-pmc · retrieved 2026-11-10T18:04:55.823Z
doaj · retrieved 2026-11-10T18:04:55.813Z